Elon Musk
@elonmusk
RT
@SERobinsonJr: xAI NEWS: Paul Conyngham, a Sydney-based tech entrepreneur and AI consultant, used Grok to finalize a mRNA vaccine construct for his dog Rosie's mast cell cancer. Paul used three AI models. He combined ChatGPT for initial ideas, AlphaFold for mutation analysis, and Grok took the mutation data and other inputs to create the final sequence for the custom mRNA vaccine targeting those exact mutations. Paul sequenced Rosie's healthy DNA and the tumor DNA for $3,000 at the University of New South Wales' (UNSW) Ramaciotti Research Centre, in Sydney, Australia. He partnered with researchers like Prof. Pall Thordarson and Prof. Martin Smith for manufacturing and injection. They reported a 75% shrinkage in one tumor.
@SERobinsonJr: xAI NEWS: Paul Conyngham, a Sydney-based tech entrepreneur and AI consultant, used Grok to finalize a mRNA vaccine construct for his dog Rosie's mast cell cancer. Paul used three AI models. He combined ChatGPT for initial ideas, AlphaFold for mutation analysis, and Grok took the mutation data and other inputs to create the final sequence for the custom mRNA vaccine targeting those exact mutations. Paul sequenced Rosie's healthy DNA and the tumor DNA for $3,000 at the University of New South Wales' (UNSW) Ramaciotti Research Centre, in Sydney, Australia. He partnered with researchers like Prof. Pall Thordarson and Prof. Martin Smith for manufacturing and injection. They reported a 75% shrinkage in one tumor.
@SERobinsonJr
xAI NEWS: Paul Conyngham, a Sydney-based tech entrepreneur and AI consultant, used Grok to finalize a mRNA vaccine construct for his dog Rosie's mast cell cancer.
Paul used three AI models. He combined ChatGPT for initial ideas, AlphaFold for mutation analysis, and Grok took the mutation data and other inputs to create the final sequence for the custom mRNA vaccine targeting those exact mutations.
Paul sequenced Rosie's healthy DNA and the tumor DNA for $3,000 at the University of New South Wales' (UNSW) Ramaciotti Research Centre, in Sydney, Australia.
He partnered with researchers like Prof. Pall Thordarson and Prof. Martin Smith for manufacturing and injection.
They reported a 75% shrinkage in one tumor.
